Skip to content

ALNYALNYLAM PHARMACEUTICALS INC

CUSIP 02043Q107 · common stock · Other share classes: 02043QAD9

4 tracked investors held ALNYLAM PHARMACEUTICALS INC (ALNY) at the end of Q3 2026, worth $532.6M in total. The largest holder was Dodge & Cox, with 0.3% of its portfolio. Lee Ainslie opened a new position this quarter.

Holders · Q3 2026
4
New holders
1
Value held
$532.6M
Quarter-end price (est.)
$246.74

Investors holding ALNY · Q3 2026

InvestorWeightSharesValueChange
Dodge & Cox
Dodge & Cox
0.27%2,006,492$495.1MADD+2.6%
Joel Greenblatt
Gotham Asset Management, LLC
0.07%149,114$36.8MADD+254.6%
Murray Stahl
Horizon Kinetics Asset Management LLC
0.01%1,960$483.6KREDUCE-9.6%
Lee Ainslie
Maverick Capital Ltd
0.00%907$223.8KNEW

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Ken Fisher0.00%6,252$1.9MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026411$532.6M$246.74
Q2 2026400$603.8M$301.03
Q1 2026411$655.5M$330.87
Q4 2025400$799.2M$397.65